Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Tacke, Frank
Trautwein, Christian
Kowdley, Kris
McCaughan, Geoffrey
and
Trautwein, Christian
2007.
Causes of death in hepatitis B and/or C virus infected–people—lessons for clinical practice†.
Hepatology,
Vol. 45,
Issue. 4,
p.
1076.
Guiltinan, Anne M.
Kaidarova, Zhanna
Custer, Brian
Orland, Jennie
Strollo, Angela
Cyrus, Sherri
Busch, Michael P.
and
Murphy, Edward L.
2008.
Increased All-Cause, Liver, and Cardiac Mortality among Hepatitis C Virus-seropositive Blood Donors.
American Journal of Epidemiology,
Vol. 167,
Issue. 6,
p.
743.
McDonald, Scott A
Hutchinson, Sharon J
Bird, Sheila M
Mills, Peter R
Dillon, John
Bloor, Mick
Robertson, Chris
Donaghy, Martin
Hayes, Peter
and
Graham, Lesley
2009.
A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland.
Statistical Methods in Medical Research,
Vol. 18,
Issue. 3,
p.
271.
Seeff, Leonard B.
2009.
The history of the “natural history” of hepatitis C (1968–2009).
Liver International,
Vol. 29,
Issue. s1,
p.
89.
GIDDING, H. F.
AMIN, J.
DORE, G. J.
and
LAW, M. G.
2011.
Hospitalization rates associated with hepatitis B and HIV co-infection, age and sex in a population-based cohort of people diagnosed with hepatitis C.
Epidemiology and Infection,
Vol. 139,
Issue. 8,
p.
1151.
Grebely, J.
Raffa, J. D.
Lai, C.
Kerr, T.
Fischer, B.
Krajden, M.
Dore, G. J.
and
Tyndall, M. W.
2011.
Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.
Journal of Viral Hepatitis,
Vol. 18,
Issue. 1,
p.
32.
Kershenobich, David
Razavi, Homie A.
Cooper, Curtis L.
Alberti, Alfredo
Dusheiko, Geoffrey M.
Pol, Stanislas
Zuckerman, Eli
Koike, Kazuhiko
Han, Kwang‐Hyub
Wallace, Carolyn M.
Zeuzem, Stefan
and
Negro, Francesco
2011.
Applying a system approach to forecast the total hepatitis C virus‐infected population size: model validation using US data.
Liver International,
Vol. 31,
Issue. s2,
p.
4.
Just, Søren Andreas
Grau, Katrine
Georgsen, Jørgen
Weis, Nina
Cowan, Susan
Groenbaek, Karin
Krarup, Henrik
and
Christensen, Peer Brehm
2012.
Long‐term follow‐up among Danish transfusion recipients identified in the national hepatitis C lookback.
Transfusion,
Vol. 52,
Issue. 3,
p.
582.
Nelson, K. E.
2012.
The Impact of Chronic Hepatitis C Virus Infection on Mortality.
Journal of Infectious Diseases,
Vol. 206,
Issue. 4,
p.
461.
Roed, Torsten
Lebech, Anne‐Mette
Kjaer, Andreas
and
Weis, Nina
2012.
Hepatitis C virus infection and risk of coronary artery disease: a systematic review of the literature.
Clinical Physiology and Functional Imaging,
Vol. 32,
Issue. 6,
p.
421.
Ridruejo, Ezequiel
2012.
Increased mortality in chronic HCV infection.
Annals of Hepatology,
Vol. 11,
Issue. 6,
p.
967.
Boulhosa, R. S. S. B.
Oliveira, L. P. M.
Jesus, R. P.
Cavalcante, L. N.
Lemaire, D. C.
Vinhas, L.
Lyra, L. G. C.
and
Lyra, A. C.
2013.
The impact of nutritional supplementation on quality of life in patients infected with hepatitis C virus.
Journal of Human Nutrition and Dietetics,
Vol. 26,
Issue. s1,
p.
7.
Kielland, Knut Boe
Skaug, Kjell
Amundsen, Ellen J.
and
Dalgard, Olav
2013.
All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: A controlled study.
Journal of Hepatology,
Vol. 58,
Issue. 1,
p.
31.
Cacoub, Patrice
Gragnani, Laura
Comarmond, Cloe
and
Zignego, Anna Linda
2014.
Extrahepatic manifestations of chronic hepatitis C virus infection.
Digestive and Liver Disease,
Vol. 46,
Issue. ,
p.
S165.
Younossi, Z. M.
Kanwal, F.
Saab, S.
Brown, K. A.
El‐Serag, H. B.
Kim, W. R.
Ahmed, A.
Kugelmas, M.
and
Gordon, S. C.
2014.
The impact of hepatitis C burden: an evidence‐based approach.
Alimentary Pharmacology & Therapeutics,
Vol. 39,
Issue. 5,
p.
518.
Sebastiani, Giada
2014.
Chronic hepatitis C and liver fibrosis.
World Journal of Gastroenterology,
Vol. 20,
Issue. 32,
p.
11033.
Innes, Hamish
Goldberg, David
Dusheiko, Geoffrey
Hayes, Peter
Mills, Peter R.
Dillon, John F.
Aspinall, Esther
Barclay, Stephen T.
and
Hutchinson, Sharon J.
2014.
Patient-important benefits of clearing the hepatitis C virus through treatment: A simulation model.
Journal of Hepatology,
Vol. 60,
Issue. 6,
p.
1118.
McEwan, Phil
Ward, Thomas
Bennett, Hayley
Kalsekar, Anupama
Webster, Samantha
Brenner, Michael
Yuan, Yong
and
Khudyakov, Yury E
2015.
Estimating the Clinical and Economic Benefit Associated with Incremental Improvements in Sustained Virologic Response in Chronic Hepatitis C.
PLOS ONE,
Vol. 10,
Issue. 1,
p.
e0117334.
Brook, Gary
Bhagani, Sanjay
Kulasegaram, Ranjababu
Torkington, Adele
Mutimer, David
Hodges, Elizabeth
Hesketh, Louise
Farnworth, Simon
Sullivan, Verity
Gore, Charles
Devitt, Emma
and
Sullivan, Ann K
2016.
United Kingdom National Guideline on the Management of the viral hepatitides A, B and C 2015.
International Journal of STD & AIDS,
Vol. 27,
Issue. 7,
p.
501.
Ghany, Marc G.
and
Liang, T. Jake
2016.
Hepatitis C Virus II.
p.
3.